IPO registrations (S-1, F-1) · Registrants
Parnell Pharmaceuticals Holdings Ltd
- SEC CIK
- 1603429 · filings on EDGAR ↗
- Former names
- PARNELL PHARMACEUTICALS HOLDINGS PTY LTD (2014–2014)
- Registration
- Form F-1, first filed 2014-05-19, last 2016-04-29; 3 initial registrations, 9 amendments
- Outcome
- Final prospectus filed 2014-06-18; declared effective 2014-06-18
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- C3
- Business address
- UNIT 4/476 GARDENERS ROAD, Alexandria, Nsw, C3 2015
- EDGAR entity type
- other
Offering terms
- Final price
- $10.00 per share (424B1 filed 2014-06-18, an initial public offering)
- Shares sold
- 5,000,000
- Gross proceeds
- $50,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol PARN
- Lead underwriters
- Jefferies (2,150,000 shares); Piper Sandler (950,000 shares)
- Syndicate
- JMP Securities (950,000); Ladenburg Thalmann (475,000); Geller Biopharm
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form D issuer: Parnell Pharmaceuticals Holdings Ltd EXACT (CIK (EXACT))
Filings 20
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2014-05-19 | F-1 | F-1 (foreign registration) | PARNELL PHARMACEUTICALS HOLDINGS PTY LTD | 0001144204-14-031813 ↗ |
| 2014-06-04 | F-1/A | F-1/A (amendment) | PARNELL PHARMACEUTICALS HOLDINGS PTY LTD | 0001144204-14-035725 ↗ |
| 2014-06-09 | F-1/A | F-1/A (amendment) | PARNELL PHARMACEUTICALS HOLDINGS PTY LTD | 0001144204-14-036344 ↗ |
| 2014-06-10 | F-1/A | F-1/A (amendment) | PARNELL PHARMACEUTICALS HOLDINGS PTY LTD | 0001144204-14-036876 ↗ |
| 2014-06-13 | F-1/A | F-1/A (amendment) | PARNELL PHARMACEUTICALS HOLDINGS PTY LTD | 0001144204-14-037545 ↗ |
| 2014-06-17 | F-1/A | F-1/A (amendment) | Parnell Pharmaceuticals Holdings Ltd | 0001144204-14-037972 ↗ |
| 2014-06-18 | F-1/A | F-1/A (amendment) | Parnell Pharmaceuticals Holdings Ltd | 0001144204-14-038196 ↗ |
| 2014-06-18 | 424B1 | 424B1 (final prospectus) | Parnell Pharmaceuticals Holdings Ltd | 0001144204-14-038348 ↗ |
| 2014-06-18 | EFFECT | EFFECT (declared effective) | Parnell Pharmaceuticals Holdings Ltd | 9999999995-14-001817 ↗ |
| 2016-01-25 | F-1 | F-1 (foreign registration) | Parnell Pharmaceuticals Holdings Ltd | 0001171843-16-007348 ↗ |
| 2016-02-12 | F-1/A | F-1/A (amendment) | Parnell Pharmaceuticals Holdings Ltd | 0001171843-16-007857 ↗ |
| 2016-02-16 | F-1/A | F-1/A (amendment) | Parnell Pharmaceuticals Holdings Ltd | 0001171843-16-007881 ↗ |
| 2016-02-16 | EFFECT | EFFECT (declared effective) | Parnell Pharmaceuticals Holdings Ltd | 9999999995-16-003782 ↗ |
| 2016-03-22 | EFFECT | EFFECT (declared effective) | Parnell Pharmaceuticals Holdings Ltd | 9999999995-16-004019 ↗ |
| 2016-04-15 | F-1 | F-1 (foreign registration) | Parnell Pharmaceuticals Holdings Ltd | 0001171843-16-009201 ↗ |
| 2016-04-29 | F-1/A | F-1/A (amendment) | Parnell Pharmaceuticals Holdings Ltd | 0001171843-16-009530 ↗ |
| 2016-05-11 | EFFECT | EFFECT (declared effective) | Parnell Pharmaceuticals Holdings Ltd | 9999999995-16-004621 ↗ |
| 2016-05-13 | 424B1 | 424B1 (final prospectus) | Parnell Pharmaceuticals Holdings Ltd | 0001171843-16-010049 ↗ |
| 2016-12-30 | EFFECT | EFFECT (declared effective) | Parnell Pharmaceuticals Holdings Ltd | 9999999995-17-000003 ↗ |
| 2016-12-30 | EFFECT | EFFECT (declared effective) | Parnell Pharmaceuticals Holdings Ltd | 9999999995-17-000004 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2014-06-18 | F-1/A | registration statement | $10.00 | 5,000,000 | $50,000,000 | Nasdaq PARN | 5 | primary document; price sentence, shares headline, proceeds computed, cover names 5 | document ↗ | |
| 2014-06-18 | 424B1 | final prospectus | $10.00 | 5,000,000 | $50,000,000 | Nasdaq PARN | 5 | primary document; price sentence, shares headline, proceeds table, underwriting table 4, cover names 5 | document ↗ |
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2016-03-04 | Parnell Pharmaceuticals Holdings Ltd | Pharmaceuticals | Indefinite | $612,500 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | Parnell Pharmaceuticals Holdings Ltd | Form D private offerings | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, C3 first:
- Pharmaxis Ltd. C3
- Propanc Biopharma, Inc. C3
- Benitec Biopharma LTD/ADR C3
- Immuron Ltd C3
- Beroni Group Ltd C3
- Medlab Clinical Ltd. C3
- Telix Pharmaceuticals Ltd C3
- MorphoSys AG 2M
- Affimed N.V. 2M
- InflaRx N.V. 2M
In other datasets, the same topic (Health) in C3:
- Form D issuer: Botanix Pharmaceuticals Ltd. (Form D private offerings)
Interests: Pharmaceutical Preparations · Health